Stockreport

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

scPharmaceuticals Inc.  (SCPH) 
Last scpharmaceuticals inc. earnings: 3/24 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: scpharmaceuticals.com
PDF Generated 4Q 2023 net FUROSCIX® revenue of $6.1 million, at the upper end of the range provided in January and representing sequential growth of 61% from $3.8 million in [Read more]